The non-contrast CT imaging market size is projected to be worth USD 226.5 million in 2023. The market is likely to surpass USD 347.5 million by 2033 at a CAGR of 4.4% during the forecast period. The non-contrast CT imaging market refers to the market for computed tomography (CT) imaging procedures that do not require the use of contrast agents.
CT imaging is a medical imaging technique that combines X-ray technology with computer processing to generate detailed cross-sectional images of the body.
Non-contrast CT imaging involves performing CT scans without the administration of contrast agents, which are substances used to enhance the visibility of certain structures or abnormalities in the body. Contrast agents are typically used in CT imaging to highlight blood vessels, organs, tumors, or other areas of interest that may be difficult to visualize without enhancement.
Other Drivers Propelling the Demand for Non-Contrast CT Imaging include:
Challenges for Companies /Manufacturers in the Non-Contrast CT Imaging Market:
Opportunities in the Non-Contrast CT Imaging Industry:
Latest Trends in the Non-Contrast CT Imaging Market:
Attributes | Details |
---|---|
Non-Contrast CT Imaging Market Size (2023) | USD 226.5 million |
Non-Contrast CT Imaging Market Projected Size (2033) | USD 347.5 million |
Value CAGR (2023 to 2033) | 4.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global non-contrast CT imaging market experienced a CAGR of 2.9%, reaching a market size of USD 226.5 million in 2023.
From 2017 to 2022, the demand for non-contrast CT imaging has been driven by several factors, including the increasing prevalence of various medical conditions, advancements in imaging technology, and the need for quick and accurate diagnostic procedures. Non-contrast CT imaging is considered safe, cost-effective, and relatively quick compared to other imaging modalities, making it a popular choice in many clinical settings.
Future Forecast for Non-Contrast CT Imaging Industry:
Looking ahead, the global non-contrast CT imaging industry is expected to rise at a CAGR of 4.4% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 347.5 million by 2033.
Non-contrast CT imaging refers to computed tomography scans performed without the use of contrast agents or dyes. It is commonly used in various medical applications, including the evaluation of brain, abdomen, pelvis, and renal conditions. Non-contrast CT imaging provides valuable diagnostic information and helps in the detection of abnormalities, such as tumors, kidney stones, and vascular diseases.
Country | The United States |
---|---|
Market Size (USD million) by End of Forecast Period (2033) | USD 146.7 million |
CAGR % 2023 to End of Forecast (2033) | 6.8% |
The non-contrast CT imaging industry in the United States is expected to reach a market size of USD 146.7 million by 2033, expanding at a CAGR of 6.8%. Non-contrast CT imaging is considered a cost-effective and efficient diagnostic tool for certain indications. It allows for quick imaging and evaluation of structures without the need for contrast agents, reducing procedure time and associated costs. This cost-effectiveness, along with the ease of use and widespread availability of CT scanners, has contributed to the growth of the non-contrast CT imaging market.
Country | The United Kingdom |
---|---|
Market Size (USD million) by End of Forecast Period (2033) | USD 23.2 million |
CAGR % 2023 to End of Forecast (2033) | 5.1% |
The non-contrast CT imaging industry in the United Kingdom is expected to reach a market value of USD 23.2 million, expanding at a CAGR of 5.1% during the forecast period. The UK's National Health Service (NHS) plays a crucial role in driving the adoption and growth of medical imaging technologies. The NHS's focus on providing quality healthcare services and timely diagnostics has led to investments in advanced imaging technologies, including non-contrast CT. Funding and support from the NHS facilitate the availability and accessibility of non-contrast CT imaging services across the country.
Country | China |
---|---|
Market Size (USD million) by End of Forecast Period (2033) | USD 43.8 million |
CAGR % 2023 to End of Forecast (2033) | 7.6% |
The non-contrast CT imaging industry in China is anticipated to reach a market size of USD 43.8 million, moving at a CAGR of 7.6% during the forecast period. China's rapid urbanization and the development of healthcare infrastructure in tier-2 and tier-3 cities have improved access to medical services, including non-contrast CT imaging. The expansion of healthcare facilities, including hospitals and imaging centers, in these areas has contributed to the growth of the market.
Country | Japan |
---|---|
Market Size (USD million) by End of Forecast Period (2033) | USD 21.0 million |
CAGR % 2023 to End of Forecast (2033) | 5.6% |
The non-contrast CT imaging industry in Japan is estimated to reach a market size of USD 21.0 million by 2033, thriving at a CAGR of 5.6%. Collaboration between academia, industry stakeholders, and healthcare providers in Japan has played a crucial role in the development and adoption of non-contrast CT imaging. Research institutions and medical facilities collaborate with industry partners to drive technological advancements, conduct clinical trials, and develop best practices. This collaboration promotes the growth of the non-contrast CT imaging market.
Country | South Korea |
---|---|
Market Size (USD million) by End of Forecast Period (2033) | USD 9.0 million |
CAGR % 2023 to End of Forecast (2033) | 5.6% |
The non-contrast CT imaging industry in South Korea is expected to reach a market size of USD 9.0 million, expanding at a CAGR of 5.6% during the forecast period. South Korea has become a popular destination for medical tourism, attracting patients from both domestic and international markets. The availability of advanced medical technologies, including non-contrast CT imaging, plays a significant role in attracting medical tourists. The growth of medical tourism has further stimulated the demand for non-contrast CT imaging services in South Korea.
Medium-Slice Scanner is expected to dominate the non-contrast CT imaging industry with a CAGR of 3.3% from 2023 to 2033. Medium-slice scanners provide better spatial resolution and image quality. Better anatomical structure visualization is made possible by this advancement, which also improves the precision of diagnostic interpretation-especially in non-contrast CT imaging. Medium-slice scanners are generally faster than older-generation scanners, allowing for quicker scan times. This is beneficial for both patients and healthcare providers, as it reduces the time required for image acquisition, enhancing patient comfort and increasing departmental efficiency.
The chest imaging segments are expected to dominate the non-contrast CT imaging industry with a CAGR of 2.8% from 2023 to 2033. Chest imaging, particularly non-contrast CT scans, is commonly used to evaluate and diagnose various respiratory conditions such as pulmonary embolism, pneumonia, lung nodules, interstitial lung diseases, and lung cancer. The demand for accurate and detailed chest imaging is driving the growth of non-contrast CT imaging.
The hospital segment is expected to dominate the non-contrast CT imaging industry with a CAGR of 3.3% from 2023 to 2033. Hospitals are the main sources of healthcare and frequently have departments for sophisticated imaging with non-contrast CT scanners. The use of non-contrast CT imaging has grown as a result of their wide distribution and accessibility to a sizable patient population. Non-contrast CT scans are conveniently accessible to patients through hospitals, facilitating rapid diagnosis and treatment.
The market for non-contrast CT imaging is highly competitive, with numerous vendors vying for supremacy. Important players must use cunning tactics in such a situation to stay ahead of the opposition.
Key Strategies Used by the Participants
To produce creative products that improve effectiveness, which is reliability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Strategic partnerships and alliances with other businesses are regularly formed by Key players in an industry to take advantage of each other's advantages and expand their market reach. Through such partnerships, companies may also obtain access to new technologies and markets.
The market for non-contrast CT imaging devices is growing quickly in emerging economies like China and India. To increase their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites.
Mergers and acquisitions are frequently used by key players in the non-contrast CT imaging business to consolidate their market position, extend their product range, and gain access to new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Non-Contrast CT Imaging Market:
In 2023, the worldwide market value could reach USD 226.5 million.
The overall market valuation is anticipated to reach nearly USD 347.5 million by 2033.
The United States leads the global market and could be valued at USD 146.7 million by 2033.
The growing demand in the United Kingdom at 5.1% may drive the Europe Market through 2033.
Cedars-Sinal, Siemens, and GE Healthcare are some top players in the global market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast 2023 to 2033 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 9.1. Low-Slice Scanners 9.2. Medium-Slice Scanners 9.3. High-Slice Scanners 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 10.1. Cardiac Imaging 10.2. Oncology 10.3. Neurology 10.4. Chest Imaging 10.5. Abdominal and Pelvic Imaging 10.6. Others 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 11.1. Hospitals 11.2. Diagnostic Imaging Centres 11.3. Ambulatory Imaging Centres 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 12.1. North America 12.2. Latin America 12.3. Europe 12.4. South Asia 12.5. East Asia 12.6. Oceania 12.7. Middle East and Africa (Middle East & Africa) 13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20. Market Structure Analysis 21. Competition Analysis 21.1. Cedars-Sinai 21.2. Siemens Healthineers 21.3. GE HealthCare 21.4. Canon Medical Systems 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports